status: 200
content-location: http://rest.kegg.jp/get/map05203
server: Apache
date: Wed, 15 Oct 2014 15:09:28 GMT
content-type: text/plain

ENTRY       map05203                    Pathway
NAME        Viral carcinogenesis
DESCRIPTION There is a strong association between viruses and the development of human malignancies. We now know that at least six human viruses, Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HCV), human papilloma virus (HPV), human T-cell lymphotropic virus (HTLV-1) and Kaposi's associated sarcoma virus (KSHV) contribute to 10-15% of the cancers worldwide. Via expression of many potent oncoproteins, these tumor viruses promote an aberrant cell-proliferation via modulating cellular cell-signaling pathways and escape from cellular defense system such as blocking apoptosis. Human tumor virus oncoproteins can also disrupt pathways that are necessary for the maintenance of the integrity of host cellular genome. Viruses that encode such activities can contribute to initiation as well as progression of human cancers.
CLASS       Human Diseases; Cancers
PATHWAY_MAP map05203  Viral carcinogenesis
DISEASE     H00007  Hodgkin lymphoma
            H00008  Burkitt lymphoma
            H00009  Adult T-cell leukemia
            H00025  Penile cancer
            H00030  Cervical cancer
            H00041  Kaposi's sarcoma
            H00044  Cancer of the anal canal
            H00048  Hepatocellular carcinoma
            H00054  Nasopharyngeal cancer
REFERENCE   PMID:18201576
  AUTHORS   McLaughlin-Drubin ME, Munger K
  TITLE     Viruses associated with human cancer.
  JOURNAL   Biochim Biophys Acta 1782:127-50 (2008)
REFERENCE   PMID:21102637
  AUTHORS   Moore PS, Chang Y
  TITLE     Why do viruses cause cancer? Highlights of the first century of human tumour virology.
  JOURNAL   Nat Rev Cancer 10:878-89 (2010)
REFERENCE   PMID:19400863
  AUTHORS   Kalland KH, Ke XS, Oyan AM
  TITLE     Tumour virology--history, status and future challenges.
  JOURNAL   APMIS 117:382-99 (2009)
REFERENCE   PMID:17979705
  AUTHORS   Boccardo E, Villa LL
  TITLE     Viral origins of human cancer.
  JOURNAL   Curr Med Chem 14:2526-39 (2007)
REFERENCE   PMID:21084867
  AUTHORS   Saha A, Kaul R, Murakami M, Robertson ES
  TITLE     Tumor viruses and cancer biology: Modulating signaling pathways for therapeutic intervention.
  JOURNAL   Cancer Biol Ther 10:961-78 (2010)
REFERENCE   PMID:21152115
  AUTHORS   Zheng ZM
  TITLE     Viral oncogenes, noncoding RNAs, and RNA splicing in human tumor viruses.
  JOURNAL   Int J Biol Sci 6:730-55 (2010)
REFERENCE   PMID:19956178
  AUTHORS   Martin D, Gutkind JS
  TITLE     Human tumor-associated viruses and new insights into the molecular mechanisms of  cancer.
  JOURNAL   Oncogene 27 Suppl 2:S31-42 (2008)
REFERENCE   PMID:16459163
  AUTHORS   Zhang X, Zhang H, Ye L
  TITLE     Effects of hepatitis B virus X protein on the development of liver cancer.
  JOURNAL   J Lab Clin Med 147:58-66 (2006)
REFERENCE   PMID:12686421
  AUTHORS   Panteva M, Korkaya H, Jameel S
  TITLE     Hepatitis viruses and the MAPK pathway: is this a survival strategy?
  JOURNAL   Virus Res 92:131-40 (2003)
REFERENCE   PMID:21647825
  AUTHORS   Ng SA, Lee C.
  TITLE     Hepatitis B virus X gene and hepatocarcinogenesis.
  JOURNAL   J Gastroenterol 46:974-990 (2011)
REFERENCE   PMID:21966251
  AUTHORS   Nishida N, Goel A
  TITLE     Genetic and epigenetic signatures in human hepatocellular carcinoma: a systematic review.
  JOURNAL   Curr Genomics 12:130-7 (2011)
REFERENCE   PMID:19854353
  AUTHORS   Benhenda S, Cougot D, Buendia MA, Neuveut C
  TITLE     Hepatitis B virus X protein molecular functions and its role in virus life cycle  and pathogenesis.
  JOURNAL   Adv Cancer Res 103:75-109 (2009)
REFERENCE   PMID:18251977
  AUTHORS   Tan A, Yeh SH, Liu CJ, Cheung C, Chen PJ
  TITLE     Viral hepatocarcinogenesis: from infection to cancer.
  JOURNAL   Liver Int 28:175-88 (2008)
REFERENCE   PMID:9343405
  AUTHORS   Klein NP, Schneider RJ
  TITLE     Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras.
  JOURNAL   Mol Cell Biol 17:6427-36 (1997)
REFERENCE   PMID:16039586
  AUTHORS   Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC
  TITLE     Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.
  JOURNAL   Mol Cell 19:159-70 (2005)
REFERENCE   PMID:21994562
  AUTHORS   Benhenda S, Cougot D, Neuveut C, Buendia MA
  TITLE     Liver cell transformation in chronic HBV infection.
  JOURNAL   Viruses 1:630-46 (2009)
REFERENCE   PMID:11099494
  AUTHORS   Diao J, Khine AA, Sarangi F, Hsu E, Iorio C, Tibbles LA, Woodgett JR, Penninger J, Richardson CD
  TITLE     X protein of hepatitis B virus inhibits Fas-mediated apoptosis and is associated  with up-regulation of the SAPK/JNK pathway.
  JOURNAL   J Biol Chem 276:8328-40 (2001)
REFERENCE   PMID:10824878
  AUTHORS   Arbuthnot P, Capovilla A, Kew M
  TITLE     Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on  apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways.
  JOURNAL   J Gastroenterol Hepatol 15:357-68 (2000)
REFERENCE   PMID:9837909
  AUTHORS   Gottlob K, Fulco M, Levrero M, Graessmann A
  TITLE     The hepatitis B virus HBx protein inhibits caspase 3 activity.
  JOURNAL   J Biol Chem 273:33347-53 (1998)
REFERENCE   PMID:15614436
  AUTHORS   Zhang JL, Zhao WG, Wu KL, Wang K, Zhang X, Gu CF, Li Y, Zhu Y, Wu JG
  TITLE     Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin.
  JOURNAL   Arch Virol 150:721-41 (2005)
REFERENCE   PMID:15105524
  AUTHORS   Cooray S
  TITLE     The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival.
  JOURNAL   J Gen Virol 85:1065-76 (2004)
REFERENCE   PMID:16939421
  AUTHORS   Mukherji A, Janbandhu VC, Kumar V
  TITLE     HBx-dependent cell cycle deregulation involves interaction with cyclin E/A-cdk2 complex and destabilization of p27Kip1.
  JOURNAL   Biochem J 401:247-56 (2007)
REFERENCE   PMID:15173177
  AUTHORS   Yoo YG, Lee MO
  TITLE     Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor.
  JOURNAL   J Biol Chem 279:36242-9 (2004)
REFERENCE   PMID:11604508
  AUTHORS   Waris G, Huh KW, Siddiqui A
  TITLE     Mitochondrially associated hepatitis B virus X protein constitutively activates transcription factors STAT-3 and NF-kappa B via oxidative stress.
  JOURNAL   Mol Cell Biol 21:7721-30 (2001)
REFERENCE   PMID:17894800
  AUTHORS   Kasprzak A, Adamek A
  TITLE     Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis.
  JOURNAL   Hepatol Res 38:1-26 (2008)
REFERENCE   PMID:9882379
  AUTHORS   You LR, Chen CM, Lee YH
  TITLE     Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha.
  JOURNAL   J Virol 73:1672-81 (1999)
REFERENCE   PMID:16581947
  AUTHORS   Sato Y, Kato J, Takimoto R, Takada K, Kawano Y, Miyanishi K, Kobune M, Sato Y, Takayama T, Matunaga T, Niitsu Y
  TITLE     Hepatitis C virus core protein promotes proliferation of human hepatoma cells through enhancement of transforming growth factor alpha expression via activation of nuclear factor-kappaB.
  JOURNAL   Gut 55:1801-8 (2006)
REFERENCE   PMID:14559998
  AUTHORS   Watashi K, Hijikata M, Tagawa A, Doi T, Marusawa H, Shimotohno K
  TITLE     Modulation of retinoid signaling by a cytoplasmic viral protein via sequestration of Sp110b, a potent transcriptional corepressor of retinoic acid receptor, from the nucleus.
  JOURNAL   Mol Cell Biol 23:7498-509 (2003)
REFERENCE   PMID:9651361
  AUTHORS   Hsieh TY, Matsumoto M, Chou HC, Schneider R, Hwang SB, Lee AS, Lai MM
  TITLE     Hepatitis C virus core protein interacts with heterogeneous nuclear ribonucleoprotein K.
  JOURNAL   J Biol Chem 273:17651-9 (1998)
REFERENCE   PMID:10873631
  AUTHORS   Wang F, Yoshida I, Takamatsu M, Ishido S, Fujita T, Oka K, Hotta H
  TITLE     Complex formation between hepatitis C virus core protein and p21Waf1/Cip1/Sdi1.
  JOURNAL   Biochem Biophys Res Commun 273:479-84 (2000)
REFERENCE   PMID:10074132
  AUTHORS   You LR, Chen CM, Yeh TS, Tsai TY, Mai RT, Lin CH, Lee YH
  TITLE     Hepatitis C virus core protein interacts with cellular putative RNA helicase.
  JOURNAL   J Virol 73:2841-53 (1999)
REFERENCE   PMID:10644344
  AUTHORS   Aoki H, Hayashi J, Moriyama M, Arakawa Y, Hino O
  TITLE     Hepatitis C virus core protein interacts with 14-3-3 protein and activates the kinase Raf-1.
  JOURNAL   J Virol 74:1736-41 (2000)
REFERENCE   PMID:17267064
  AUTHORS   Yan XB, Battaglia S, Boucreux D, Chen Z, Brechot C, Pavio N
  TITLE     Mapping of the interacting domains of hepatitis C virus core protein and the double-stranded RNA-activated protein kinase PKR.
  JOURNAL   Virus Res 125:79-87 (2007)
REFERENCE   PMID:9060639
  AUTHORS   Borowski P, Oehlmann K, Heiland M, Laufs R
  TITLE     Nonstructural protein 3 of hepatitis C virus blocks the distribution of the free  catalytic subunit of cyclic AMP-dependent protein kinase.
  JOURNAL   J Virol 71:2838-43 (1997)
REFERENCE   PMID:10405893
  AUTHORS   Borowski P, Kuhl R, Laufs R, Schulze zur Wiesch J, Heiland M
  TITLE     Identification and characterization of a histone binding site of the non-structural protein 3 of hepatitis C virus.
  JOURNAL   J Clin Virol 13:61-9 (1999)
REFERENCE   PMID:12101418
  AUTHORS   Lan KH, Sheu ML, Hwang SJ, Yen SH, Chen SY, Wu JC, Wang YJ, Kato N, Omata M, Chang FY, Lee SD
  TITLE     HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis.
  JOURNAL   Oncogene 21:4801-11 (2002)
REFERENCE   PMID:12925958
  AUTHORS   Chung YL, Sheu ML, Yen SH
  TITLE     Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma.
  JOURNAL   Int J Cancer 107:65-73 (2003)
REFERENCE   PMID:10400746
  AUTHORS   Gale M Jr, Kwieciszewski B, Dossett M, Nakao H, Katze MG
  TITLE     Antiapoptotic and oncogenic potentials of hepatitis C virus are linked to interferon resistance by viral repression of the PKR protein kinase.
  JOURNAL   J Virol 73:6506-16 (1999)
REFERENCE   PMID:12186904
  AUTHORS   He Y, Nakao H, Tan SL, Polyak SJ, Neddermann P, Vijaysri S, Jacobs BL, Katze MG
  TITLE     Subversion of cell signaling pathways by hepatitis C virus nonstructural 5A protein via interaction with Grb2 and P85 phosphatidylinositol 3-kinase.
  JOURNAL   J Virol 76:9207-17 (2002)
REFERENCE   PMID:15795286
  AUTHORS   Street A, Macdonald A, McCormick C, Harris M
  TITLE     Hepatitis C virus NS5A-mediated activation of phosphoinositide 3-kinase results in stabilization of cellular beta-catenin and stimulation of beta-catenin-responsive transcription.
  JOURNAL   J Virol 79:5006-16 (2005)
REFERENCE   PMID:11886269
  AUTHORS   Majumder M, Ghosh AK, Steele R, Zhou XY, Phillips NJ, Ray R, Ray RB
  TITLE     Hepatitis C virus NS5A protein impairs TNF-mediated hepatic apoptosis, but not by an anti-FAS antibody, in transgenic mice.
  JOURNAL   Virology 294:94-105 (2002)
REFERENCE   PMID:11278402
  AUTHORS   Arima N, Kao CY, Licht T, Padmanabhan R, Sasaguri Y, Padmanabhan R
  TITLE     Modulation of cell growth by the hepatitis C virus nonstructural protein NS5A.
  JOURNAL   J Biol Chem 276:12675-84 (2001)
REFERENCE   PMID:21250384
  AUTHORS   He Y, Staschke KA, Tan SL
  TITLE     HCV NS5A: A Multifunctional Regulator of Cellular Pathways and Virus Replication
  JOURNAL   (2006)
REFERENCE   PMID:12379483
  AUTHORS   Qadri I, Iwahashi M, Simon F
  TITLE     Hepatitis C virus NS5A protein binds TBP and p53, inhibiting their DNA binding and p53 interactions with TBP and ERCC3.
  JOURNAL   Biochim Biophys Acta 1592:193-204 (2002)
REFERENCE   PMID:22110506
  AUTHORS   Spender LC, Inman GJ
  TITLE     Inhibition of germinal centre apoptotic programmes by epstein-barr virus.
  JOURNAL   Adv Hematol 2011:829525 (2011)
REFERENCE   PMID:20494113
  AUTHORS   Klein G, Klein E, Kashuba E
  TITLE     Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes.
  JOURNAL   Biochem Biophys Res Commun 396:67-73 (2010)
REFERENCE   PMID:21372216
  AUTHORS   Saha A, Robertson ES
  TITLE     Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.
  JOURNAL   Clin Cancer Res 17:3056-63 (2011)
REFERENCE   PMID:15510157
  AUTHORS   Young LS, Rickinson AB.
  TITLE     Epstein-Barr virus: 40 years on.
  JOURNAL   Nat Rev Cancer 4:757-68 (2004)
REFERENCE   PMID:14506283
  AUTHORS   Holowaty MN, Sheng Y, Nguyen T, Arrowsmith C, Frappier L
  TITLE     Protein interaction domains of the ubiquitin-specific protease, USP7/HAUSP.
  JOURNAL   J Biol Chem 278:47753-61 (2003)
REFERENCE   PMID:11160754
  AUTHORS   Harada S, Yalamanchili R, Kieff E
  TITLE     Epstein-Barr virus nuclear protein 2 has at least two N-terminal domains that mediate self-association.
  JOURNAL   J Virol 75:2482-7 (2001)
REFERENCE   PMID:15452270
  AUTHORS   Peng CW, Zhao B, Kieff E
  TITLE     Four EBNA2 domains are important for EBNALP coactivation.
  JOURNAL   J Virol 78:11439-42 (2004)
REFERENCE   PMID:15767449
  AUTHORS   Peng R, Moses SC, Tan J, Kremmer E, Ling PD
  TITLE     The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated  stimulation of latent membrane proteins expressed from the viral divergent promoter.
  JOURNAL   J Virol 79:4492-505 (2005)
REFERENCE   PMID:21177815
  AUTHORS   Saha A, Bamidele A, Murakami M, Robertson ES
  TITLE     EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5.
  JOURNAL   J Virol 85:2079-88 (2011)
REFERENCE   PMID:21347341
  AUTHORS   Saha A, Halder S, Upadhyay SK, Lu J, Kumar P, Murakami M, Cai Q, Robertson ES
  TITLE     Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing  and enhancing the function of cyclin D1.
  JOURNAL   PLoS Pathog 7:e1001275 (2011)
REFERENCE   PMID:15542638
  AUTHORS   Knight JS, Sharma N, Kalman DE, Robertson ES
  TITLE     A cyclin-binding motif within the amino-terminal homology domain of EBNA3C binds  cyclin A and modulates cyclin A-dependent kinase activity in Epstein-Barr virus-infected cells.
  JOURNAL   J Virol 78:12857-67 (2004)
REFERENCE   PMID:14747563
  AUTHORS   Knight JS, Robertson ES
  TITLE     Epstein-Barr virus nuclear antigen 3C regulates cyclin A/p27 complexes and enhances cyclin A-dependent kinase activity.
  JOURNAL   J Virol 78:1981-91 (2004)
REFERENCE   PMID:16352731
  AUTHORS   Knight JS, Sharma N, Robertson ES
  TITLE     Epstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligase.
  JOURNAL   Proc Natl Acad Sci U S A 102:18562-6 (2005)
REFERENCE   PMID:18391203
  AUTHORS   Kashuba E, Yurchenko M, Yenamandra SP, Snopok B, Isaguliants M, Szekely L, Klein G
  TITLE     EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexes.
  JOURNAL   Proc Natl Acad Sci U S A 105:5489-94 (2008)
REFERENCE   PMID:11091847
  AUTHORS   Young LS, Dawson CW, Eliopoulos AG
  TITLE     The expression and function of Epstein-Barr virus encoded latent genes.
  JOURNAL   Mol Pathol 53:238-47 (2000)
REFERENCE   PMID:19078975
  AUTHORS   Kuppers R
  TITLE     The biology of Hodgkin's lymphoma.
  JOURNAL   Nat Rev Cancer 9:15-27 (2009)
REFERENCE   PMID:17049016
  AUTHORS   Pattle SB, Farrell PJ
  TITLE     The role of Epstein-Barr virus in cancer.
  JOURNAL   Expert Opin Biol Ther 6:1193-205 (2006)
REFERENCE   PMID:11905817
  AUTHORS   Thorley-Lawson DA
  TITLE     Epstein-Barr virus: exploiting the immune system.
  JOURNAL   Nat Rev Immunol 1:75-82 (2001)
REFERENCE   PMID:11669605
  AUTHORS   Eliopoulos AG, Young LS
  TITLE     LMP1 structure and signal transduction.
  JOURNAL   Semin Cancer Biol 11:435-44 (2001)
REFERENCE   PMID:11766888
  AUTHORS   Dell G, Gaston K
  TITLE     Human papillomaviruses and their role in cervical cancer.
  JOURNAL   Cell Mol Life Sci 58:1923-42 (2001)
REFERENCE   PMID:10793105
  AUTHORS   zur Hausen H
  TITLE     Papillomaviruses causing cancer: evasion from host-cell control in early events in carcinogenesis.
  JOURNAL   J Natl Cancer Inst 92:690-8 (2000)
REFERENCE   PMID:19156753
  AUTHORS   Yugawa T, Kiyono T
  TITLE     Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins.
  JOURNAL   Rev Med Virol 19:97-113 (2009)
REFERENCE   PMID:17645777
  AUTHORS   Narisawa-Saito M, Kiyono T
  TITLE     Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles  of E6 and E7 proteins.
  JOURNAL   Cancer Sci 98:1505-11 (2007)
REFERENCE   PMID:15342967
  AUTHORS   Motoyama S, Ladines-Llave CA, Luis Villanueva S, Maruo T
  TITLE     The role of human papilloma virus in the molecular biology of cervical carcinogenesis.
  JOURNAL   Kobe J Med Sci 50:9-19 (2004)
REFERENCE   PMID:20592731
  AUTHORS   Moody CA, Laimins LA
  TITLE     Human papillomavirus oncoproteins: pathways to transformation.
  JOURNAL   Nat Rev Cancer 10:550-60 (2010)
REFERENCE   PMID:15956361
  AUTHORS   McCance DJ
  TITLE     Human papillomaviruses and cell signaling.
  JOURNAL   Sci STKE 2005:pe29 (2005)
REFERENCE   PMID:18385245
  AUTHORS   Wade R, Brimer N, Vande Pol S
  TITLE     Transformation by bovine papillomavirus type 1 E6 requires paxillin.
  JOURNAL   J Virol 82:5962-6 (2008)
REFERENCE   PMID:9374493
  AUTHORS   Berezutskaya E, Bagchi S
  TITLE     The human papillomavirus E7 oncoprotein functionally interacts with the S4 subunit of the 26 S proteasome.
  JOURNAL   J Biol Chem 272:30135-40 (1997)
REFERENCE   PMID:16381817
  AUTHORS   Zhang B, Chen W, Roman A
  TITLE     The E7 proteins of low- and high-risk human papillomaviruses share the ability to target the pRB family member p130 for degradation.
  JOURNAL   Proc Natl Acad Sci U S A 103:437-42 (2006)
REFERENCE   PMID:12970441
  AUTHORS   He W, Staples D, Smith C, Fisher C
  TITLE     Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.
  JOURNAL   J Virol 77:10566-74 (2003)
REFERENCE   PMID:9349482
  AUTHORS   Massimi P, Pim D, Banks L
  TITLE     Human papillomavirus type 16 E7 binds to the conserved carboxy-terminal region of the TATA box binding protein and this contributes to E7 transforming activity.
  JOURNAL   J Gen Virol 78 ( Pt 10):2607-13 (1997)
REFERENCE   PMID:8617242
  AUTHORS   Antinore MJ, Birrer MJ, Patel D, Nader L, McCance DJ
  TITLE     The human papillomavirus type 16 E7 gene product interacts with and trans-activates the AP1 family of transcription factors.
  JOURNAL   EMBO J 15:1950-60 (1996)
REFERENCE   PMID:9990017
  AUTHORS   Zwerschke W, Mazurek S, Massimi P, Banks L, Eigenbrodt E, Jansen-Durr P
  TITLE     Modulation of type M2 pyruvate kinase activity by the human papillomavirus type 16 E7 oncoprotein.
  JOURNAL   Proc Natl Acad Sci U S A 96:1291-6 (1999)
REFERENCE   PMID:17384582
  AUTHORS   Matsuoka M, Jeang KT
  TITLE     Human T-cell leukaemia virus type 1 (HTLV-1) infectivity and cellular transformation.
  JOURNAL   Nat Rev Cancer 7:270-80 (2007)
REFERENCE   PMID:15310405
  AUTHORS   Azran I, Schavinsky-Khrapunsky Y, Aboud M
  TITLE     Role of Tax protein in human T-cell leukemia virus type-I leukemogenicity.
  JOURNAL   Retrovirology 1:20 (2004)
REFERENCE   PMID:12910250
  AUTHORS   Matsuoka M
  TITLE     Human T-cell leukemia virus type I and adult T-cell leukemia.
  JOURNAL   Oncogene 22:5131-40 (2003)
REFERENCE   PMID:11244044
  AUTHORS   Yoshida M
  TITLE     Multiple viral strategies of HTLV-1 for dysregulation of cell growth control.
  JOURNAL   Annu Rev Immunol 19:475-96 (2001)
REFERENCE   PMID:18702816
  AUTHORS   Boxus M, Twizere JC, Legros S, Dewulf JF, Kettmann R, Willems L
  TITLE     The HTLV-1 Tax interactome.
  JOURNAL   Retrovirology 5:76 (2008)
REFERENCE   PMID:8223437
  AUTHORS   Caron C, Rousset R, Beraud C, Moncollin V, Egly JM, Jalinot P
  TITLE     Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP.
  JOURNAL   EMBO J 12:4269-78 (1993)
REFERENCE   PMID:8756622
  AUTHORS   Clemens KE, Piras G, Radonovich MF, Choi KS, Duvall JF, DeJong J, Roeder R, Brady JN
  TITLE     Interaction of the human T-cell lymphotropic virus type 1 tax transactivator with transcription factor IIA.
  JOURNAL   Mol Cell Biol 16:4656-64 (1996)
REFERENCE   PMID:16036567
  AUTHORS   Harhaj EW, Harhaj NS
  TITLE     Mechanisms of persistent NF-kappaB activation by HTLV-I tax.
  JOURNAL   IUBMB Life 57:83-91 (2005)
REFERENCE   PMID:21743832
  AUTHORS   Qu Z, Xiao G
  TITLE     Human T-cell lymphotropic virus: a model of NF-kappaB-associated tumorigenesis.
  JOURNAL   Viruses 3:714-49 (2011)
REFERENCE   PMID:16155601
  AUTHORS   Kashanchi F, Brady JN
  TITLE     Transcriptional and post-transcriptional gene regulation of HTLV-1.
  JOURNAL   Oncogene 24:5938-51 (2005)
REFERENCE   PMID:14530271
  AUTHORS   Wu K, Bottazzi ME, de la Fuente C, Deng L, Gitlin SD, Maddukuri A, Dadgar S, Li H, Vertes A, Pumfery A, Kashanchi F
  TITLE     Protein profile of tax-associated complexes.
  JOURNAL   J Biol Chem 279:495-508 (2004)
REFERENCE   PMID:16155604
  AUTHORS   Grassmann R, Aboud M, Jeang KT
  TITLE     Molecular mechanisms of cellular transformation by HTLV-1 Tax.
  JOURNAL   Oncogene 24:5976-85 (2005)
REFERENCE   PMID:16308315
  AUTHORS   Tabakin-Fix Y, Azran I, Schavinky-Khrapunsky Y, Levy O, Aboud M
  TITLE     Functional inactivation of p53 by human T-cell leukemia virus type 1 Tax protein: mechanisms and clinical implications.
  JOURNAL   Carcinogenesis 27:673-81 (2006)
REFERENCE   PMID:16760382
  AUTHORS   Rezaee SA, Cunningham C, Davison AJ, Blackbourn DJ
  TITLE     Kaposi's sarcoma-associated herpesvirus immune modulation: an overview.
  JOURNAL   J Gen Virol 87:1781-804 (2006)
REFERENCE   PMID:17457345
  AUTHORS   Coscoy L
  TITLE     Immune evasion by Kaposi's sarcoma-associated herpesvirus.
  JOURNAL   Nat Rev Immunol 7:391-401 (2007)
REFERENCE   PMID:21040832
  AUTHORS   Cai Q, Verma SC, Lu J, Robertson ES
  TITLE     Molecular biology of Kaposi's sarcoma-associated herpesvirus and related oncogenesis.
  JOURNAL   Adv Virus Res 78:87-142 (2010)
REFERENCE   PMID:16828973
  AUTHORS   Jarviluoma A, Ojala PM
  TITLE     Cell signaling pathways engaged by KSHV.
  JOURNAL   Biochim Biophys Acta 1766:140-58 (2006)
REFERENCE   PMID:18948197
  AUTHORS   Liang C, Lee JS, Jung JU
  TITLE     Immune evasion in Kaposi's sarcoma-associated herpes virus associated oncogenesis.
  JOURNAL   Semin Cancer Biol 18:423-36 (2008)
REFERENCE   PMID:19715458
  AUTHORS   Lee HR, Kim MH, Lee JS, Liang C, Jung JU
  TITLE     Viral interferon regulatory factors.
  JOURNAL   J Interferon Cytokine Res 29:621-7 (2009)
REFERENCE   PMID:22566809
  AUTHORS   Jacobs SR, Damania B
  TITLE     The Viral Interferon Regulatory Factors of KSHV: Immunosuppressors or Oncogenes?
  JOURNAL   Front Immunol 2:19 (2011)
REFERENCE   PMID:19651473
  AUTHORS   Wen KW, Damania B
  TITLE     Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.
  JOURNAL   Cancer Lett 289:140-50 (2010)
REFERENCE   PMID:15967719
  AUTHORS   Wang HW, Boshoff C
  TITLE     Linking Kaposi virus to cancer-associated cytokines.
  JOURNAL   Trends Mol Med 11:309-12 (2005)
REFERENCE   PMID:15692053
  AUTHORS   McCormick C, Ganem D
  TITLE     The kaposin B protein of KSHV activates the p38/MK2 pathway and stabilizes cytokine mRNAs.
  JOURNAL   Science 307:739-41 (2005)
REFERENCE   PMID:12770701
  AUTHORS   Verma SC, Robertson ES
  TITLE     Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus.
  JOURNAL   FEMS Microbiol Lett 222:155-63 (2003)
REFERENCE   PMID:10354594
  AUTHORS   Schulz TF, Moore PS
  TITLE     Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how?
  JOURNAL   Trends Microbiol 7:196-200 (1999)
REFERENCE   PMID:10855768
  AUTHORS   Schulz TF
  TITLE     Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8): epidemiology and pathogenesis.
  JOURNAL   J Antimicrob Chemother 45 Suppl T3:15-27 (2000)
REFERENCE   PMID:9594662
  AUTHORS   Moore PS, Chang Y
  TITLE     Antiviral activity of tumor-suppressor pathways: clues from molecular piracy by KSHV.
  JOURNAL   Trends Genet 14:144-50 (1998)
REFERENCE   PMID:20534855
  AUTHORS   Pietrek M, Brinkmann MM, Glowacka I, Enlund A, Havemeier A, Dittrich-Breiholz O, Kracht M, Lewitzky M, Saksela K, Feller SM, Schulz TF
  TITLE     Role of the Kaposi's sarcoma-associated herpesvirus K15 SH3 binding site in inflammatory signaling and B-cell activation.
  JOURNAL   J Virol 84:8231-40 (2010)
REFERENCE   PMID:21421561
  AUTHORS   Bagneris C, Briggs LC, Savva R, Ebrahimi B, Barrett TE
  TITLE     Crystal structure of a KSHV-SOX-DNA complex: insights into the molecular mechanisms underlying DNase activity and host shutoff.
  JOURNAL   Nucleic Acids Res 39:5744-56 (2011)
REFERENCE   PMID:15919895
  AUTHORS   Glaunsinger B, Chavez L, Ganem D
  TITLE     The exonuclease and host shutoff functions of the SOX protein of Kaposi's sarcoma-associated herpesvirus are genetically separable.
  JOURNAL   J Virol 79:7396-401 (2005)
KO_PATHWAY  ko05203
///
